Obacunone, a Promising Phytochemical Triterpenoid: Research Progress on Its Pharmacological Activity and Mechanism

Author:

Zhou Yuyang12ORCID,Gu Jifeng34,Li Jiahui15,Zhang Huishan1,Wang Mei1,Li Yuanyuan6,Wang Tianming6,Wang Jiajie17,Shi Rong1

Affiliation:

1. Science and Technology Experimental Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

2. Department of Pharmacology, Addiction Science and Toxicology, University of Tennessee Health Science Center, College of Medicine, Memphis, TN 38163, USA

3. Shanghai Key Laboratory of Bioactive Small Molecules, Fudan University, Shanghai 200032, China

4. Department of Pharmacy, Eye & ENT Hospital, Fudan University, Shanghai 200031, China

5. Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China

6. Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

7. Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China

Abstract

Obacunone, a natural triterpenoid, is an active component of the herbs Dictamnus dasycarpus Turcz. and Phellodendron amurense Rupr, and an indicator of the herbs’ quality. Owing to its multiple health benefits, several studies have investigated the multi-targeting potential action mechanisms of obacunone. To summarize recent developments on the pharmacological actions of obacunone and focus on the underlying molecular mechanisms and signaling networks, we searched PubMed, Europe PMC, Wiley Online Library, Web of Science, Google Scholar, Wanfang Medical Network, and China National Knowledge Infrastructure for articles published prior to March 2024. Existing research indicates obacunone has great potential to become a promising therapeutic option against tumors, fibrotic diseases, bone and cholesterol metabolism diseases, and infections of pathogenic microorganisms, among others. The paper contributes to providing up-to-date references for further research and clinical applications of obacunone.

Funder

National Natural Science Foundation of China

Shanghai Science and Technology Innovation Action Plan—Biomedical Science Technology Support Project

Innovative Research Team of High-Level Local Universities in Shanghai and a Key Laboratory Program of the Education Commission of Shanghai Municipality

Shanghai Municipal Health Commission

Publisher

MDPI AG

Reference106 articles.

1. Research Progress in Biological Activity and Structure-activity Relationship of Limon;Han;Prog. Pharm. Sci.,2015

2. National Pharacopoeia Comission (2020). Pharmacopoeia of the People’s Republic of China, China Medical Science Press.

3. Therapeutic targets and pharmacological mechanisms of Coptidis rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis;Yang;Front. Pharmacol.,2022

4. Study on the molecular mechanism of anti-liver cancer effect of Evodiae fructus by network pharmacology and QSAR model;Chen;Front. Chem.,2023

5. Lippia javanica (Burm. F.) Herbal Tea: Modulation of Hepatoprotective Effects in Chang Liver Cells via Mitigation of Redox Imbalance and Modulation of Perturbed Metabolic Activities;Salau;Front. Pharmacol.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3